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ABSTRACT
Malaria transmission in Madagascar is highly heterogeneous, exhibiting spatial, seasonal and long-
term trends. Previous efforts to map malaria risk in Madagascar used prevalence data from Malaria
Indicator Surveys. These cross-sectional surveys, conducted during the high transmission season
most recently in 2013 and 2016, provide nationally representative prevalence data but cover relatively
short time frames. Conversely, monthly case data are collected at health facilities but suffer from
biases, including incomplete reporting.
We combined survey and case data to make monthly maps of prevalence between 2013 and 2016.
Health facility catchments were estimated and incidence surfaces, environmental and socioeconomic
covariates, and survey data informed a Bayesian prevalence model. Prevalence estimates were
consistently high in the coastal regions and low in the highlands. Prevalence was lowest in 2014 and
peaked in 2015, highlighting the importance of estimates between survey years. Seasonality was
widely observed. Similar multi-metric approaches may be applicable across sub-Saharan Africa.
Keywords Malaria · Geostatistics · Bayesian · Prevalence ·Madagascar · Incidence
1 Introduction
Malaria is a major public health problem in Madagascar, with an estimated 2.16 million cases leading to more than
5000 deaths in the country in 2018 [1]. Malaria burden decreased in the early 2000s with an increase in control efforts
but this progress was largely halted following political turmoil in 2009 [2, 3, 4] resulting in a resurgence in endemicity
in the last decade [4, 5, 1, 6].
Malaria transmission is highly heterogeneous across Madagascar, reflecting the diverse ecological landscape of the
island. Transmission is highest in the east and west coastal regions, where it follows a seasonal pattern with clinical
incidence peaking between February and May depending on location. In the central highlands and the desert south,
transmission is lower and annual trends are less consistent, with temporal variation appearing to be driven by outbreak
dynamics [4, 7, 8]. Howes et al. [4] identified eight contiguous ecozones representing distinct transmission settings
(Central highlands, Highlands fringe west, Highlands fringe east, Northeast, Northwest, Southeast, Southwest, South)
which are shown in Figure 1(a). When devising the 2018–2022 malaria National Strategic Plan, the National Malaria
Control Programme (NMCP) of Madagascar classified 106 of the 114 districts in Madagascar as control areas, 3
pre-elimination and- 5 elimination, based on reported case numbers in 2016 [9]. Control strategies are currently
stratified by risk level, with intermittent preventative treatment for pregnant women (IPTp) and mass distribution of
insecticide-treated bed nets (ITNs) in the 106 control districts and indoor residual spraying (IRS) targeted at high
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transmission districts in the southeast and southwest. In pre-elimination settings the focus is on outbreak and active
case detection [10, 11].
Routine malaria case data are collected through the Health Management Information System (HMIS) from reports
from health facilities. These data are collected monthly and have a high spatial coverage (see Figure 2) but also
suffer from a number of potential biases. This passive case detection is unlikely to capture all malaria cases in the
community, missing those that do not seek care or do so from informal or private providers, which likely represents
a large fraction of the population (treatment-seeking rates in the public sector in 2013 were estimated to be around
45%) [12, 13, 14]. Furthermore, cases seen at health facilities may not be diagnosed or reported to the central
system due to resource constraints (such as malaria rapid diagnostic test (RDT) stock-outs) or weak communication
infrastructure [4]. Nevertheless, while these data may not represent all malaria incidence, they are an important source
of information on trends in transmission due to their high temporal and spatial coverage [4, 6, 8, 15, 16].
Malaria Indicator Surveys (MIS) provide another source of data for understanding the spatiotemporal patterns of malaria
endemicity [17, 13, 14]. These cross-sectional surveys are designed to be nationally representative and collect data on a
number of indicators, including prevalence of Plasmodium falciparum infection in individuals between 6 and 59 months
of age. They are conducted with a standardised methodology applied over all sites and surveys and, unlike routine case
data, are not affected by reporting incompleteness, treatment-seeking behaviour or standards for clinical diagnosis. For
these reasons, prevalence information from national health surveys has traditionally been the primary source of data for
mapping malaria risk in sub-Saharan Africa [18, 19, 3, 5]. Kang et al. [5] used a Bayesian hierarchical model to map
prevalence in Madagascar in 2011, 2013 and 2016 using parasite prevalence data from the 2011, 2013 and 2016 MIS
reports [17, 13, 14]. However, cross-sectional surveys provide limited insight into seasonal patterns of transmission or
transmission in years when no survey took place. Variation in the timing of surveys between years may also make it
difficult to distinguish changes in prevalence between survey years from seasonal variation. Moreover, survey data is
less informative in low burden areas, where sample sizes are likely to be inadequate to accurately assess changes in
transmission due to low rates of detectable parasitaemia [20].
In this study, we combined routine case data and prevalence survey data within a formal modelling framework,
taking advantage of their relative strengths, in order to provide a more complete understanding of the spatiotemporal
heterogeneity of transmission between 2013 and 2016. From the routine case data, we produced spatially smooth
monthly incidence surfaces which were then used as a covariate in a Bayesian geostatistical model of prevalence. This
approach is similar to the use of modelled prevalence surfaces to map incidence [21] and the use of other modelled
surfaces, such as temperature suitability [22] or accessibility [23], as inputs when mapping malaria risk [18, 19, 3, 5].
The use of both incidence and prevalence data is also similar to the work of Lucas et al. [24] combining prevalence and
aggregated incidence data in a joint model. However, the two-step modelling process used here is conceptually simpler
than a joint model and allows the relationship between incidence and prevalence to be learned within the prevalence
model (rather than imposing a previously estimated relationship, such as [25]). An important benefit of learning this
relationship is that systematic biases in routine case data are implicitly accounted for. Modelling the incidence and
prevalence processes separately is equivalent to making a ‘cut’ between the incidence and prevalence processes in the
model. Modularising the inference in this way also prevents over-reliance on the less reliable incidence data in the final
prevalence estimates [26, 27]. We incorporated routine case data to update the estimates of prevalence for 2013 and
2016 made by Kang et al. [5] and to produce estimates for 2014 and 2015. By producing monthly prevalence maps over
all four years, both long term and seasonal trends in prevalence across the country could be assessed. We used the eight
ecozones identified by Howes et al. [4] as a basis for assessing how these trends vary spatially.
2 Methods
2.1 Study data
Parasite prevalence data was available from Malaria Indicator Surveys that took place in Madagascar in 2013 and 2016.
These data consist of geo-located clusters where the prevalence of P. falciparum infection was measured, determined
by microscopy, in individuals between 6 and 59 months of age (PfPR6−59mo). These surveys were conducted with a
standard protocol and survey sites were selected to produce nationally representative estimates of prevalence in this
age group. The number of positive individuals and the total number tested was recorded at each site. In the 2013 and
2016 surveys, 6323 and 6927 individuals were screened across 274 and 358 sites, respectively. The survey sites and
proportions of positive individuals are shown in Figure 1(b) and full details can be found in the original reports [13, 14].
Monthly health facility case data between January 2013 and December 2016 were provided by the NMCP. These data
come from HMIS data reports and represent clinical cases of malaria confirmed by an RDT for all ages, irrespective of
parasite species. Data were available from 3342 health facilities in Madagascar, of which 2801 were geo-located and
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Figure 1: (a) Ecozones defined by Howes et al. [4] representing contiguous areas with distinct patterns of transmission.
(b) Prevalence rates at survey sites in the 2013 and 2016 MIS.
verified using a separate dataset of geo-located health facilities from the Institut Pasteur de Madagascar (as described in
[8]).
A number of covariates were used to inform the prevalence model, which are detailed in Table 1. Most of these variables
were environmental, influencing vector abundance, parasite behaviour and environmental suitability. Two of these
covariates (accessibility to cities [23] and night lights [28]) relate to the development and urbanicity of a location and
therefore are related to vector abundance and to socioeconomic factors, such as access to healthcare. In total there were
26 potential features for the prevalence model – 8 static covariates and 6 dynamic covariates, each considered at 0, 1
and 2 month time lags. Causal feature selection [29] was used to select the variables included in the final model.
2.2 Catchment population
In order to calculate incidence rates at each health facility, estimates for catchment populations (the number of people
likely to seek treatment at each facility) were needed. A catchment model was used to estimate these (treatment-seeking)
catchment populations, based on travel time to health facilities. The country was divided into a grid of approximately
5km-by-5km pixels. For each pixel, the travel time to each health facility was calculated using a friction surface
(defining travel time through each pixel) developed by Weiss et al. [23] and a least cost algorithm [37]. Given that an
individual in pixel i seeks treatment, the probability they seek treatment in health facility j, p(pixeli → HFj), was
modelled as inversely proportional to square of the travel time to that health facility. That is,
p(pixeli → HFj) =
t(pixeli → HFj)−2∑NHF
j=1 t(pixeli → HFj)−2
where t(pixeli → HFj) represents the travel time from pixel i to health facility j and NHF was the total number of
health facilities. The catchment population of health facility j was then calculated as
Npixel∑
i=1
populationi × p(pixeli → HFj)
where populationi is the treatment seeking-adjusted population of pixel i and Npixel is the total number of pixels. The
proportion of the population in each pixel who would seek treatment at any health facility was also modelled as a
function of travel time, which has been identified as an important factor in treatment-seeking behaviour for fever in
Madagascar [38]. This proportion was modelled as a logistic function (similar to the functional forms considered by
Alegana et al. [39])
α
1 + exp(σt)
+ β
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Table 1: List of covariates.
Covariate Description Type In any causal
feature set
In final fea-
ture set
Rainfall [30] Climate Hazards Group Infrared Precipitation with
Station Data
Dynamic Lag 0 Lag 0
LST day [31] Daytime land surface temperature Dynamic No No
LST night [31] Night-time land surface temperature Dynamic Lag 1 No
TCB [32] Tasselled cap brightness; measure of land re-
flectance
Dynamic Lag 2 No
EVI [33] Enhanced vegetation index Dynamic No No
TSI Pf [22] Temperature suitability index for P. falciparum Dynamic Lag 2 No
Accessibility
[23]
Distance to cities with population > 50,000 Static Yes Yes
AI [34] Aridity index Static Yes Yes
Elevation [35] Elevation as measured by the Shuttle Radar Topog-
raphy Mission (SRTM)
Static Yes No
PET [34] Potential evapotranspiration Static Yes No
Slope [35] GIS-derived surface calculated from SRTM eleva-
tion surface
Static Yes No
Night lights [28] Index that measures the presence of lights from
towns, cities and other sites with persistent lighting
Static No No
Distance to water
[36]
GIS-derived surface that measures distance to per-
manent and semi-permanent water based on pres-
ence of lakes, wetlands, rivers and streams, and
accounting for slope and precipitation
Static Yes Yes
TWI [35] Topographic wetness index Static No No
where t is the travel time to the nearest health facility in minutes. The parameters values α = 0.6, σ = 0.00916,
β = 0.15 were chosen such that the maximum and minimum possible treatment-seeking proportions were 0.6 and 0.15,
and the treatment-seeking proportion at t = 120 minutes was 0.3. These parameter values were chosen to produce a
similar relationship between treatment-seeking and travel time as that observed in the 2013 and 2016 MISs [13, 14]
(see supplementary material Figure 3) and match overall estimated treatment-seeking rates [12]. Catchment populations
were calculated for each year between 2013 and 2016 using hybrid population surfaces from the Gridded Population
of the World v4 [40] and WorldPop [41]. In order to assess the sensitivity of the final estimates to these modelling
assumptions, three alternative sets of populations were considered: catchment populations supplied by the NMCP
(based on the 1993 national census adjusted by a fixed annual growth rate [42] with no adjustment for treatment-seeking
behaviour) and two sets of catchment populations generated by the catchment model under different treatment-seeking
parameters (see supplementary material). The analysis was repeated using these catchment populations and the resulting
prevalence estimates were compared.
2.3 Incidence model
Routine case data from health facilities were modelled using a Bayesian geospatial model to produce monthly incidence
surfaces which were then used as inputs to the prevalence model. Let cit be the number of cases observed in month t
(t =1, ..., 48) at health facility i (i =1, ..., N ), which is at location si and has a treatment-seeking catchment population
Ei. The number of cases observed was modelled as a Poisson process
cit ∼ Pois(Ei × λit)
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with mean equal to the product of the catchment population and the underlying incidence rate, λit. The log incidence
rate was modelled as
log λit = β0 + f(si, t)
where β0 was an intercept and for each month f(·, t) was a realisation of a Gaussian process over space with zero
mean and Mátern covariance structure. The Mátern covariance function is parameterised by the range, ρ, and marginal
variance, σ2, the values of which were chosen by a search over parameter space to maximise accuracy when predicting
incidence in held out locations. These parameters were optimised jointly over all months. The value of smoothness
parameter, ν, was fixed at 1.
2.4 Prevalence model
Prevalence data from MIS surveys were also modelled using a Bayesian geospatial model, informed by environmental
and socioeconomic covariates and the modelled incidence surfaces. Let yi be the number of infected individuals and Ni
be the number of individuals tested in survey i (i = 1, ..., M ), taking place in location si at time ti. The results of the
survey were modelled as a realisation of a binomial process
yi ∼ Binomial(pi, Ni)
with underlying prevalence pi at this location and point in time. The logit-transformed prevalence was modelled as
logit(pi) = β0 + β
TXi + β
inc
0 g(λ(si, ti)) + β
inc
1 g(λ(si, ti + 1)) + f(si)
where β0,β, βinc0 , β
inc
1 were parameters (with β
inc
0 and β
inc
1 non-negative), Xi were covariate values and λ(s, t) was
the log incidence value from the modelled incidence surfaces at location s and time t. f was modelled as a realisation
of a Gaussian process over space with Mátern covariance, parameterised by the range ρ and marginal variance σ2,
while g is a realisation of a Gaussian process over incidence with a squared exponential kernel, parameterised by
the scale κ (with fixed variance 1). This allowed a non-linear effect of incidence on logit-prevalence while limiting
model-complexity by assuming a priori that this relationship is smooth (by the choice of squared exponential kernel and
placing an appropriate prior on the scale parameter). This flexibility was important as incidence is likely to be the main
driver of prevalence in the model (while the additional covariates are likely to be less informative and therefore were
modelled as having linear effects) and assuming a linear effect produces prevalence-incidence relationships that do not
match empirical observations [25]. Incidence in the subsequent month was included in addition to incidence in the
current month, as the presence of parasites in the blood could result in a clinical case that is recorded in a health centre
several weeks later. The parameters βinc0 and β
inc
1 allowed the model to learn the relative predictive power of incidence
at these two time points.
The Bayesian model was completed by placing appropriate priors on the parameters and hyperparameters. Normal
priors were placed on β0,β, βinc0 , β
inc
1 centred around 0 with standard deviation 1 for β0 and 0.25 for β, β
inc
0 , β
inc
1 . The
Mátern covariance parameters were given log-normal priors with mean 3 and standard deviation 0.1 for ρ and mean 0
and standard deviation 0.1 for σ, shrinking the spatial term towards a fairly flat and smooth field. A log-normal prior
was placed on κ with mean 3 and standard deviation 0.1. Both the incidence and prevalence models were fitted using the
Gaussian Markov Random Field approximation [43] with the Template Model Builder package [44] in R and samples
were drawn from a Laplace approximation to the posterior to produce associated uncertainty estimates. The model
was validated by fitting the model with data from the 2013 survey and making predictions for 2016 (to evaluate model
performance when predicting prevalence in previously unobserved time points) and through k-fold cross validation.
2.5 Feature selection
The covariates included in the prevalence model were selected from the potential covariates described in Table 1 using
causal feature selection [29, 45]. In total there were 29 potential features, 18 dynamic (6 covariates each at 0, 1 and 2
month time lags) and 8 static. The idea behind causal feature selection is to select features with the most direct causal
relationships to the response based on the available data.
We describe the procedure briefly here which is described in full detail by Arambepola et al. [29]. The PC algorithm [46],
a causal discovery algorithm, was used to infer causal relationships between the different features and malaria prevalence.
In particular, the output of this algorithm identified all direct causes of prevalence. To quantify the certainty of these
direct causes, the algorithm was repeatedly applied to bootstrapped samples of the data. The certainty of a feature being
a direct cause of prevalence was then quantified as the proportion of repeats in which it was inferred to be a direct
cause. For a given minimum certainty, feature sets were then generated by selecting all direct causes of prevalence and
a number of potential feature sets were generated by varying the minimum certainty required between 0 and 1. Out
of these potential feature sets, the final set chosen was the feature set which maximised the cross-validated predictive
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performance of the model. The causal discovery algorithm relies on conditional independence testing. We used the
Randomized Conditional Independence Test [47] to perform scalable non-parametric conditional independence tests.
Selecting causal features may be beneficial for a number of reasons. It is possible that causal selection may lead
to smaller feature sets, especially in situations in which many features are associated with the response variable but
relatively few are directly causal [45]. Small feature sets may improve computational efficiency and reduce overfitting.
Models built on causal feature sets may also be more robust to common problems such as concept drift and covariate
shift [48] and therefore make more useful predictions further forward in time or in previously unobserved locations.
Arambepola et al. [29] showed that using causal feature selection resulted in improved performance when forecasting
malaria incidence compared to classical feature selection.
3 Results
3.1 Catchment populations
The median size of the modelled catchment populations was 2890 (LQ: 1710, UQ: 4740). The total population served
according to the modelled populations increased from 10.15 million in 2013 to 11.02 million in 2016, corresponding
to approximately 43% of the Malagasy population each year, which is largely in agreement with estimated treatment-
seeking rates [12].
3.2 Incidence
Annual incidence rates at each health facility (calculated using reported cases and modelled catchment populations) are
shown in Figure 2. Spatial patterns of incidence in 2013 and 2016 were similar to observed prevalence (Figure 1(b))
with lower rates in the central highlands and the south, and higher rates in the east and west coastal regions. Compared
to 2013, incidence in 2016 was generally higher in health facilities in the southeast and southwest but lower in the
north. Across the four years, rates were generally lowest in 2014 (with the exception of the east coast) and highest in
2015. Figure 3 shows monthly incidence rates aggregated by ecozone. A seasonal pattern of a single peak in incidence
between January and April can be seen to some extent in most regions, most clearly in the Southeast, Northeast and
(despite low overall incidence) Highland fringe east ecozones. An increase in cases in 2015 was observed in almost all
ecozones.
The optimal hyperparameters for the incidence model were ρ = e−0.1 and σ = e−2. Figure 4 shows the smooth
incidence surfaces produced by this model aggregated annually, which as expected reflect the overall spatiotemporal
trend of the observed data. It should be noted that these surfaces were only intended to be a spatial smoothing of the
treatment seeking-adjusted case data reflecting relative spatial trends, rather than an enumeration of true incidence rates,
and are an intermediate step in the modelling process rather than an output.
3.3 Prevalence
The causal discovery algorithm identified 4 dynamic and 4 static feature sets which combined to give 16 potential
feature sets for the prevalence model. The features that were present in at least one of these sets are listed in Table 1
and these sets are listed in full in the supplementary material. The features used in the final model were rainfall [30]
with no time lag, accessibility to cities [23], an aridity index [34] and distance to water [36]. The posterior mean and
95% credible interval for all the model parameters, including coefficients of these features, are shown in Table 2. As
expected, incidence was the most important predictor, with incidence in the current month having a greater effect
than incidence in the following month. The other covariates in the model had smaller and less consistent effects on
prevalence. When fitting the model on 2013 data and making predictions for 2016, there was a correlation of 0.63
between predicted and observed values. For 3, 4 and 5-fold cross-validation, there were average correlations of 0.58,
0.59 and 0.6, respectively. These values are reasonably high given that the observed prevalence rates are themselves
noisy point estimates of underlying prevalence; for context, the standard errors of the mean of binomial samples of
20 individuals (the median survey size) with true prevalence values of 0.01, 0.05 and 0.15 are 0.022, 0.049 and 0.080,
respectively.
Prevalence estimates for individuals between 6 and 59 months of age are shown aggregated annually in Figure 5. Spatial
patterns were similar across all four years, with highest estimated prevalence near the southeast coast and other areas of
high prevalence along the west coast. Prevalence estimates were consistently low in the far south of the country and in
the central highlands. Prevalence in the north varied more between years, although was generally low or moderately low.
Population-weighted mean prevalence was lowest in 2014 (6.0%, 95% credible interval (CI): 3.3-8.8), followed by 2013
(6.4%, CI: 3.5-9.5) and 2016 (6.6%, CI: 3.6-9.6), and was highest in 2015 (8.9%, CI: 4.6-12.9). Population-weighted
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Figure 2: Annual incidence rates at each health facility based on routine case data and modelled catchment populations.
Table 2: Mean and 95% credible intervals for the prevalence model parameters.
Parameter Mean CI
Intercept -3.956 -6.082, -1.926
Accessibility 0.060 -0.021, 0.150
AI -0.066 -0.172, 0.042
Distance to water -0.031 -0.108, 0.042
Rainfall (no lag) 0.019 -0.097, 0.128
log ρ 1.48 1.263, 1.693
log σ -0.762 -0.968, -0.561
log λinc 1.883 0.881, 3.043
βinc0 0.802 0.407, 1.22
βinc1 0.497 0.184, 0.879
prevalence over time (Figure 6) showed a clear seasonal pattern, peaking between February and April each year with
the lower prevalence occurring between July and September. Prevalence was highest in 2015, with the peak prevalence
across all four years occurring in April 2015 (11.4%, CI: 5.8-16.0) and notably high prevalence sustained into the lower
transmission season. By the second half of 2016, prevalence appeared to have returned to similar levels to 2013 and
2014.
Figure 7 shows the mean prevalence over time for each ecozone. Prevalence was consistently highest in the Southeast
ecozone, with peak monthly prevalence of 0.3 or more in all years, while consistently lowest in the Central highlands
and Highland fringe east ecozones. Seasonal patterns of prevalence are present in most of these ecozones, including
both higher transmission regions (Northeast, Southeast and Southwest) and the lower transmission highland ecozones.
These regional seasonal trends are similar to the pattern observed for mean prevalence across the country, with a single
peak occurring between February and April in most areas (though often earlier in the Southeast ecozone) and lowest
prevalence around August. The Northwest and South ecozones exhibit some similar seasonal trends but these are less
consistent. In most areas, prevalence in 2014 was slightly lower than in 2013, with large decreases in the Northwest
and South ecozones. Increased prevalence in 2015 was observed in all areas. In the highland ecozones, prevalence
was higher than normal around April but later in the year returned to similar levels to previous years. In the rest of
the country, a high peak in April was generally followed by higher than average prevalence throughout the rest of
the year and into 2016. The average prevalence in 2016 (also shown in Figure 5) is shown again in Figure 8 with
ecozone borders highlighted. The ecozones generally correspond well to these latest prevalence estimates. The greatest
7
Figure 3: Monthly incidence rates at each health facility based on routine case data and modelled catchment populations
stratified by ecozone (2013-2016).
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Figure 4: Incidence surfaces for all ages aggregated annually.
Figure 5: Annual prevalence estimates for individuals between 6 and 59 months of age.
heterogeneity within ecozones was in the Highland fringe west ecozone, which contained a region of higher prevalence
to the south, and the Northwest ecozone.
Figure 9 shows two ways of visualising the uncertainty in prevalence estimates, using annual 2016 estimates as an
example. The first (Figure 9(a)) maps the interquartile range of the posterior distribution. The spatial patterns of
uncertainty are similar to the prevalence estimates, with higher (absolute) uncertainty areas of high prevalence. An
alternative quantification of uncertainty is in terms of probability of estimates exceeding (or not exceeding) chosen
values. Figure 9(b) shows the probability of prevalence (sampled from the posterior distribution) exceeding 0.15. This
can be interpreted as the probability that the true prevalence in 2016 exceeded 0.15. In the majority of the country
there is a very high certainty that prevalence was below 0.15, while on the east and west coasts there is fairly high
confidence that prevalence exceeded this value. In the southwest, in particular, the probability of exceeding 0.15 is
often above 90%. Similarly, we can visualise the probability of not exceeding a certain value, as shown in Figure 9(c)
with the probability of not exceeding 0.05. Here we can identify areas in the highlands, south and far north where there
is very high confidence of low prevalence. We also see more areas around the north where there is less certainty, with
probabilities between 20-50% of prevalence not exceeding 0.05. Maps of uncertainty in 2013, 2014 and 2015 using the
interquartile range and exceedance probabilities are included in the supplementary material (supplementary material
Figures 5-7).
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Figure 6: Population-weighted mean parasite prevalence over time with 95% credible interval.
The sensitivity analysis performed using different catchment populations showed that our prevalence estimates were
fairly robust to different methods of estimating these populations. Despite the systematic differences between these
estimates, leading to significantly different incidence estimates (supplementary material Figure 1), the resulting
prevalence estimates were very similar (supplementary material Figure 2).
4 Discussion
Our results highlight the benefits of combining routine case data and cross-sectional survey data to provide a more
complete understanding of prevalence over time. While the 2013 and 2016 MIS data show similar levels of prevalence
in these two years, the routine case data suggests there was substantial variation in transmission between these time
points, with decreasing case numbers in 2014 followed by a marked increase in 2015. Incorporating this case data
into a formal modelling framework allowed us to quantify these trends in terms of changes in prevalence over time.
The robust two-step modelling approach allowed us to learn from these noisy data sources effectively while retaining
flexibility in important model components, in particular the incidence-to-prevalence relationship.
By producing monthly risk maps we are able to assess temporal trends of interest in detail. For example, in much of
the country the increase in prevalence in 2015 was caused by increased prevalence throughout the year and into early
2016, rather than only higher than average prevalence during the high transmission season. The observed increase
in cases in 2015 has been attributed to cyclones and the resulting flooding and lack of supplies in many parts of the
country [49]. Our results may help confirm this or identify other factors driving these increases in transmission (and
similarly the decreases in 2014). We can also distinguish regions where prevalence appears to have returned to normal
levels by the second half of 2016 from regions where increased transmission appears to have been sustained, such as the
South and Highland fringe west ecozones. The latter may be potential targets for increased control efforts. Monthly
prevalence estimates allowed us to evaluate seasonal trends in prevalence. These trends were largely similar across the
country, with one seasonal peak occurring between February and April. This seasonality was clear in many of the high
transmission areas but was also observed in highland ecozones, despite the low overall prevalence in these regions. A
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Figure 7: Population-weighted mean prevalence over time stratified by ecozone with 95% credible interval.
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Figure 8: Prevalence estimates for 2016 with ecozones borders shown in black.
Figure 9: Uncertainty in 2016 annual prevalence estimates expressed with (a) interquartile range, (b) probability of
prevalence exceeding 0.15 and (c) probability of prevalence not exceeding 0.05.
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better understanding of baseline transmission patterns in low transmission settings may improve outbreak detection [7]
or influence plans for moving towards pre-elimination and elimination in these areas.
We can also consider the long term trends over the four years in the context of the ITN mass distribution campaigns
(MDCs) which have taken place approximately every three years since 2009 [11]. The second MDC took place in
November 2012 on the east coast and October 2013 in the rest of the country and the third from September to December
2015 [50, 51]. Although continuous ITN distribution was carried out to supplement these campaigns, a decline in net
coverage and effectiveness over time could be a factor in the overall increase in estimated burden up to the end of 2015.
When comparing our results to the MIS data, the prevalence estimates from the MIS reports of 9.1% in 2013 [13] and
7.0% in 2016 [14] are higher than our annual point estimates (6.4% and 6.6% respectively) but are consistent with
our credible intervals. However, our results show limited evidence of a decrease in prevalence in 2016 compared to
2013. It appears likely that the decrease observed in the raw data is a consequence of the timing of the 2016 survey
which primarily took place between May and July, around a month later than the 2013 survey and slightly past the
seasonal peak in prevalence for the year. The annual 2013 and 2016 risk maps made by Kang et al. [5] show a similar
spatial pattern to our results, with low rates of prevalence in the highlands and south of the country and higher rates
in the east and west coasts. However, Kang et al. [5] estimate high prevalence in the north of the country, whereas in
our results areas of higher prevalence are largely in the northeast. Similar to our results, their estimates show very
similar prevalence in 2013 and 2016, although in general the overall mean estimated is slightly higher (9.3% in 2016)
than our point estimates. We can also compare the monthly estimates of prevalence in each ecozone. While in many
regions overall seasonal trends were largely similar, the monthly prevalence estimates made by Kang et al. [5] show
less consistent seasonal patterns with greater uncertainty. We would expect the monthly estimates in our analysis to
be more robust, particularly outside of the survey months (April - June in 2013 and May - July in 2016) and in lower
transmission areas, as there is more data to inform each month.
Comparing prevalence estimates to the routine case data, we can see that the temporal patterns in prevalence are
typically smoothed trends from the case data (due to the spatial smoothing when producing the incidence surfaces
and the temporal smoothing from using incidence at two time points to the predict prevalence). However, we can see
distinct spatial trends in the prevalence estimates, for example prevalence was consistently highest in the Southeast
ecozone in the whole study period despite similar or higher observed incidence rates in the Southwest ecozone from
April 2015 onwards.
As well as visualising uncertainty using the interquartile range, we have used maps of exceedance (and non-exceedance)
probabilities. In practice, the latter may be more interpretable and therefore more useful for communicating uncertainty.
By choosing relevant thresholds, exceedance surfaces may be useful for identifying areas that are estimated to be high
transmission with high confidence or areas that are most likely to be considered pre-elimination.
4.1 Limitations
A key modelling input in this study was monthly incidence rates at each health facility, which depend on the estimated
catchment populations. Our model for estimating these catchment populations is based only on travel time to each
health facility and does not take into account other factors that may influence treatment-seeking or choice of facility,
such as type of facility [52, 38]. However, the results of our analysis when using catchment population estimates from
the NMCP and when varying treatment-seeking behaviour (see supplementary material Figures 1 and 2) demonstrate
that our modelling approach is fairly robust to differences in catchment population estimates. This is likely due to the
spatial smoothing of incidence data and learned incidence-to-prevalence relationship. Treatment-seeking behaviour
may also vary throughout the year, which is not accounted for in this analysis and may bias monthly estimates of
prevalence. Modelling these temporal dynamics is extremely challenging, with limited treatment-seeking data available
and behaviour that is likely to vary on a small spatial scale based on local infrastructure and geography.
A strength of our approach is the ability to account for bias in reporting of case information due to the learned relationship
between prevalence and incidence. However, differences in reporting across the country cannot be accounted for in this
relationship (which is constant across time and space). Howes et al. [4] investigated the spatial variation in reporting in
2014 by looking at RDT stock-outs and proportion of distributed RDTs for which any result was reported to the HMIS
by district. The proportion of RDT results reported was generally higher on the west coast, and therefore prevalence
in this region may be somewhat overestimated, but across the rest of the country there were no strong spatial trends
in reporting. Similarly, increases in reported cases over time may be partly due to increased access to healthcare or
availability of RDTs, leading to overestimates of prevalence in more recent years, although the use of survey data in the
first and last years of our study period should mitigate this.
Although the case data used in this study was for a different age range (all ages) to the estimates of prevalence (6-59
months), we believe this is unlikely to bias our estimates. There was a strong relationship between the number of cases
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in individuals under 5 and all ages in the routine case data (correlation of 0.91 across all health facilities and months)
and the relationship between incidence and prevalence was learned within the model. Therefore we would expect the
predictive power of incidence in either age range to be similar. Incidence for all ages was chosen due to the larger
sample sizes in the data, which should produce more reliable estimates of incidence.
The aim of this study was to estimate prevalence, however estimates of incidence may be of more use for public health
purposes (for example, district-level risk stratification by the NMCP is based on estimated incidence [9]). Future
work could therefore focus on mapping incidence. A common approach for generating incidence estimates is to use
prevalence estimates and an established prevalence-incidence relationship [19, 3]. This approach is generally used
where prevalence estimates are informed only by prevalence survey data (where routine case data is unavailable or too
unreliable to be used) but a similar transformation could be applied to the prevalence estimates produced here. A more
direct way of combining routine case data and survey data to estimate incidence would be to use a joint model [24]. To
do so successfully would likely require a more complete understanding of the spatiotemporal trends in treatment-seeking
and reporting completeness in order to account for bias in the routine case data due to these factors.
5 Conclusion
In this study, we used routine case data and survey data to produce monthly estimates of malaria prevalence between
2013 and 2016. Our results suggest that while malaria endemicity was similar in 2013 and 2016, there was considerable
variation in the intervening period, with a small decrease in 2014 followed by a substantial increase in 2015. In many
areas, this increase in prevalence was sustained throughout 2015 and early 2016, and in the Northwest and South
ecozones prevalence had yet to return to 2014 levels by the end of 2016. Seasonality of transmission (with a single peak
around March) was widely observed in high transmission areas and in some low transmission areas. The relative spatial
patterns of prevalence were mostly consistent over time, with highest prevalence in the southwest and high prevalence
in the southeast. Prevalence was consistently low in the highlands and in the south of the country.
The Bayesian modelling approach applied here allowed us to make prevalence estimates with associated measures
of uncertainty by learning temporal trends in transmission from the routine case data and calibrating these trends to
prevalence observations from the survey data. These risk estimates could be an important tool for assessing the impact
of control measures and the progress made towards the goals set out by the NMCP [10, 11] and for better understanding
the drivers of changes in transmission. Our results demonstrate the considerable additional information that can be
gained by combining data sources in this way. While previous risk mapping efforts produced monthly prevalence
maps for 2011, 2013 and 2016 [5], these were informed by a relatively small number of prevalence observations from
surveys which only covered 3 months of each year. We were able to make monthly maps of prevalence over a four year
period (including years in which no surveys took place), informed by a large amount of monthly case data in addition to
the survey data. Our sensitivity analysis demonstrated that these estimates are robust to varying assumptions about
treatment-seeking behaviour and reporting incompleteness.
Incomplete reporting, treatment-seeking behaviour, and inconsistent standardisation of clinical diagnoses affect the
quality of routine case data in many countries of sub-Saharan Africa [53]. Consequently, the World Health Organization
estimates for malaria burden are often based on community prevalence surveys alone [1, 23]. The methods presented
here may be a useful starting point for incorporating routine case data into estimates of malaria burden more widely.
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